Melanoma Clinical Trial
Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma
Summary
Subjects are randomized to one of two treatment arms. All subjects are screened for eligibility within 28 days prior to randomization. The study consists of a treatment phase and a follow-up phase. Subjects will be treated in repeating 4 week cycles.
Eligibility Criteria
Understand and voluntarily sign an informed consent form.
Able to adhere to the study visit schedule and other protocol requirements.
Metastatic malignant melanoma now stage IV, relapsed or refractory to standard metastatic therapy.
Women of childbearing potential must have a negative serum or urine pregnancy test within 7 days of starting study drug.
Patients with active brain disease, or newly diagnosed brain metastases, within 4 weeks prior to the start of study treatment are excluded.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 31 Locations for this study
Tucson Arizona, 85724, United States
Los Angeles California, 90089, United States
Los Angeles California, 90095, United States
San Francisco California, 94109, United States
Santa Monica California, 90404, United States
Aurora Colorado, 80010, United States
Waterbury Connecticut, 06708, United States
Lakeland Florida, 33804, United States
Miami Beach Florida, 33140, United States
Park Ridge Illinois, 60068, United States
Urbana Illinois, 61801, United States
Boston Massachusetts, 02214, United States
Boston Massachusetts, 02215, United States
Grand Rapids Michigan, 49503, United States
Columbia Missouri, 65203, United States
St. Louis Missouri, 63110, United States
St. Louis Missouri, 63131, United States
New York New York, 10016, United States
New York New York, 10021, United States
Cincinnati Ohio, 45219, United States
Cleveland Ohio, 44195, United States
Hershey Pennsylvania, 17033, United States
Pittsburgh Pennsylvania, 15232, United States
Nashville Tennessee, 37203, United States
Houston Texas, 77030, United States
Calgary Alberta, T2N 4, Canada
Edmonton Alberta, T6G 1, Canada
Winnipeg Manitoba, R3E 0, Canada
Halifax Nova Scotia, B3H 2, Canada
Toronto Ontario, M5G 2, Canada
Quebec , PQ G1, Canada
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.